Upregulation of cryptotanshinone on the expression of p-STAT5 supported protection against ischemic stroke (Zhu et al., 2021), whereas the inhibitory effect of cryptotanshinone effectively antagonized chronic myelocytic leukemia (CML) (Dong et al., 2018). This evidence concerns the gene STAT5A and ischemic stroke.